Sharon Chang

Medical Lead for TKI APAC CoE (Apr 2024 - Present)

• Represented APAC CoE in global meetings, advocating for regional needs and contributing to global strategy development.
• Led community surveys and regional events across APAC countries, enhancing collaboration and scientific engagements.
• Served as a global liaison, facilitating support in medical affairs and evidence generation across APAC countries.

Key Achievements in Strategy and Innovation:

• Pioneered the launch of the first shared decision-making toolkits for prostate cancer in Taiwan, a global first for Bayer, enhancing patient empowerment and clinical communication.
• Established Taiwan's inaugural patient advisory board, creating a collaborative platform for optimizing prostate cancer management and improving treatment outcomes.

Consensus Publication Leadership:

• Spearheaded a cross-border multidisciplinary medical advisory board, resulting in the first consensus publication on mHSPC management in Taiwan, marking a significant contribution to medical knowledge.

Evidence Generation and RWE Innovation:

• Initiated and managed three Investigator-Initiated Research (IIR) projects and several Non-Interventional Studies (NIS), including RAPIT, focusing on closing clinical practice gaps and building Real-World Evidence (RWE).

Clinical Operational Support and Scientific Expertise:

• Acted as a liaison and scientific expert for Site Initiation Visits (SIVs), enhancing the operational execution of oncology portfolio clinical trials.
• Led the first train-the-trainer series post-global medical APEX meeting, significantly expanding the network of advocates and improving scientific communication.

Cross-Functional Collaboration and Team Leadership:

• Coached and guided a team of three Medical Science Liaisons (MSLs), promoting effective collaboration and enhancing team performance.
• Developed localized sentiment categories based on global guidance, improving Thought Leader (TL) engagement and cross-functional team collaboration.

Recognition

• Bayer Best Employee Award (2024): Honored for exceptional workplace achievements, particularly noted for contributions to successful product launches and demonstrating exemplary teamwork.
• Team Performance Award (TPA) (2023): Received in recognition of exceptional contributions to team goals and project success. This award highlights my leadership in driving team performance, fostering innovation, and collaborating effectively to achieve outstanding results.

Therapeutic area lead in Inflammation and Respiratory Diseases

• Strategy Execution: Spearheaded the development and implementation of strategic plans aimed at improving patient care, enhancing access, and supporting product launches in the inflammation and respiratory diseases domain. Built consensus on diagnosis and treatment guidelines for rare diseases through partnerships with key scientific societies.
• Cross-Functional Collaboration and Team Leadership: Successfully coached and mentored two Medical Science Liaisons (MSLs), enhancing their strategic engagement abilities, scientific communication skills, and overall performance. Drove cross-functional execution of key strategies, including facilitating clinical studies, organizing peer-to-peer medical and scientific exchanges, and building collaborations with medical, scientific, and patient communities. Provided critical insights for asset issue resolution.
• Data Generation: Led data generation activities in phases II-IV and Real-World Evidence (RWE) phase, identifying research projects, centers, and investigators to support reimbursement plans. Launched the Compassionate Use Program, enabling access to life-saving therapies for patients across key medical centers in Taiwan.
• Advisory and Symposium Organization: Directed cross-border advisory boards and expert input forums, organizing 10 symposia within key international/national congresses to foster scientific exchange.
• Regulatory Strategy: Played a key role in regulatory and market access strategies, addressing compliance, regulatory, and public relations matters related to asset safety and quality.
• Training and Development: Developed and executed training programs for sales, marketing, and medical teams, enhancing team knowledge and operational efficiency.
• Recognition: Received the BI-AAI Star Employee (Local) Award in 2022 for exceptional workplace achievements and the Best Medical Excellence Sharing (Global) Award for creating a forum for regional scientific exchange.
• Operational Excellence: Met operational and budget targets, addressing administrative and clinical needs effectively.

• Stakeholder Management: Conveyed and executed scientific and business needs appropriately and effectively across internal and external stakeholders. Responsible for all medical inquiries from external stakeholders and CV/CNS customers.
• Advisory: Steered advisory boards and expert input forums. Built relationships with the external scientific community with peer-to-peer research and educational collaborations, as well as interactions with scientific societies, health organizations, and publications. Organized 2 cross-border advisory board meetings, 4 national scientific exchange meetings, and 10 symposia within key international congresses.
• Regulatory and Market Access: Supported resolution of regulatory, PR, compliance, and other asset issues. Contributes content and strategy in regulatory interactions and risk management planning.
• Training: Developed and drove country trainings for sales, marketing, and medical teams. Covered cross-functional training for Hong Kong for 6 months, demonstrating versatility and the ability to adapt training programs to different regions.

Global Experience:

• Mentored by the global CV medical lead, who invited me to join her team's strategic planning meetings and participate in organizing global medical advisory boards and scientific events at global congresses for 9 months.
• Invited to share best practices on Real-World Evidence (RWE) buildup in TW.

• Led research project and conducted research to identify factors influencing general practitioners’ decisions to diagnose, treat, or refer patients with suspected melanoma in Australia, and published associated paper.
• Conducted research on general practitioners’ attitudes towards sentinel lymph node biopsy, and published associated paper.
• Developed research basis after literature review, analyzed qualitative and quantitative data, and interpreted findings.

• Served as a primary care physician specializing in family and occupational medicine. Provided inpatient and outpatient care, coordinated care, and referred patients to specialists.
• Provided expert knowledge of medical policies, procedures, and ethical standards to various industries and corporate boards.
• Engaged in clinical and academic research by conducting literature review, proposing a theory, performing statistics analysis, and carrying out experimentation.
• Supervised and provided for the educational needs junior residents, interns, and medical students.

• Rotated through all specialties as a primary care general resident physician. Provided well-rounded care to patients with complex cases in collaboration with other physicians, specialists, and healthcare providers.
• Engaged in clinical trial research and case series studies by conducting literature review, proposing a theory, and carrying out experimentation.
• Awarded the Annual Best Teamwork and Knowledge Award (2015) and Best Intern Award (2015).